A PYMNTS Company

US: Aetna sells $1bn in assets to mitigate antitrust concerns over Humana merger

By  |  July 6, 2016

Hartford, Conn.-based Aetna will auction a portfolio of its Medicare Advantage assets in hopes of soothing antitrust concerns over its pending merger with Louisville, Ky.-based Humana, Reuters reported.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The auction comes as the insurer requests antitrust approval for its $37 billion acquisition of Humana. If approved, Aetna and Humana’s combined Medicare Advantage business would be the US’s largest manager of health insurance for seniors and the disabled. Aetna hopes the sale will assuage antitrust concerns, Reuters reported.

    The insurer will start collecting bids next week, and already sent out pitchbooks to possible buyers. The sale may take several months, and its effect on antitrust approval is uncertain. The assets are expected to be valued around $1 billion, according to the report.

    Full Content: Health Care Dive

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.